ɂ‚ >> English Guide >> English Guide of JKMA

English Guide of JKMA

Introduction of Commissions and Committees

Business Ethics Committee
Centered on top management in member companies, and newly established in April 2011 to meet social responsibilities based on compliance with laws and ordinances and a high sense of ethics.

Chairman
Terukazu Kato, Tsumura & Co.

Ethical Kampo Products Commission
Ethical Kampo Products Commission consists of 12 member companies handling ethical Kampo formulation and its bulk extracts.

Chairman
Terukazu Kato, Tsumura & Co.

Ethical Kampo Products Committee
Chairman
Hisashi Hasegawa, Tsumura & Co.
  Subcommittee for Promoting Proper Usage
Head
Hiroyuki Matsuzuka, Kracie Pharmaceutical, Ltd.
  Usability Research Subcommittee
Head
Miyuki Minari, Tsumura & Co.
  Education and Training Subcommittee
Head
Hiroshi Nakai, Tsumura & Co.
Crude Drugs Commission
Crude Drugs Commission consists of 34 member companies handling raw materials for crude drug (captive consumption, sales), and companies handling crude drug for dispensing and other final products.

Chairman
Naokazu Uchida, Uchida Wakanyaku Ltd.

Crude Drugs Committee
Chairman
Hiroshi Asama, Uchida Wakanyaku Ltd.
  Team for Domestic Crude Drug Production
Head
Takemi Hirate, Tsumura & Co.
  Crude Drug Project Subcommittee
Head
Hiroshi Sasaki, Nippon Funmatsu Yakuhin Co., Ltd.
  Crude Drug Cultivation Subcommittee
Head
Tomohiro Matsuba, Tsumura & Co.
  Crude Drug Distribution Subcommittee
Head
Yutaka Yamamoto, Tochimoto Tenkaido Co., Ltd.
OTC Kampo Products Commission
OTC Kampo Products Commission consists of 40 member companies handling OTC Kampo formulation.

Chairman
Sadao Furuichi, Kracie Pharmaceutical, Ltd.

OTC Kampo Products Committee
Chairman
Yoshiaki Nagashima, Kracie Pharmaceutical, Ltd.
  Drugs Consultation Subcommittee
Head
Keiji Mori, Kotaro Pharmaceutical Co., Ltd.
  Prescription Subcommittee
Head
Kikumi Takahashi, Tsumura & Co.
  Subcommittee for Promoting Proper Usage
Head
Yoshiaki Nagashima, Kracie Pharmaceutical, Ltd.
Crude Drug Products Commission
Crude Drug Products Commission consists of 27 member companies handling crude drug formulation.

Chairman
Yutaka Kobayashi, Kobayashi Pharmaceutical Co., Ltd.

Crude Drug Products Committee
Chairman
Atsunori Wada, Kobayashi Pharmaceutical Co., Ltd.
  System Research Subcommittee
  Formulation Development Subcommittee
Head
Kenichi Wakabayashi, Kobayashi Pharmaceutical Co., Ltd.
Bulk Extracts Commission
Bulk Extracts Commission consists of 6 member companies manufacturing all types of extracts such as tinctures, dry extracts and so on.

Chairman
Shoichi Kuwano, Nippon Funmatsu Yakuhin Co., Ltd.

Bulk Extracts Committee
Chairman
Hiroshi Sasaki, Nippon Funmatsu Yakuhin Co., Ltd.
General Affairs Committee

Chairman
Kunihiko Sugasawa, Tsumura & Co.

  General Affairs Subcommittee
Head
Kunihiko Sugasawa, Tsumura & Co.
  Project Subcommittee
Head
Ryozo Matsumoto, Kotaro Pharmaceutical Co., Ltd.
  Environmental Subcommittee
Head
Hiroyuki Utagawa, Tsumura & Co.
Public Relations Committee

Chairman
Noboru Suzuki, Tsumura & Co.

  Web Project Subcommittee
Head
Minoru Nakajima, Tsumura & Co.
International Committee

Chairman
Hidemi Shiomoto, Taisho Pharmaceutical Co., Ltd.

Pharmaceutical Regulations Committee

Chairman
Hirokazu Kurita, Kracie Pharmaceutical, Ltd.

Technical Committee

Chairman
Kazuhiro Matsumoto, Tsumura & Co.

  Test Method Subcommittee
Head
Seizo Kondo, Kotaro Pharmaceutical Co., Ltd.
  Impurity Test Method Subcommittee
Head
Hidehiro Ando, Kotaro Pharmaceutical Co., Ltd.
  Technical Quality Subcommittee
Head
Hitoshi Katagiri, Uchida Wakanyaku Ltd.
  Crude Drug Quality Subcommittee
Head
Tsuguo Yokokura, Nippon Funmatsu Yakuhin Co., Ltd.
Safety Committee

Chairman
Masafumi Tsukamoto, Tsumura & Co.

  Reevaluation Subcommittee
Head
Hideki Agenosono, Tsumura & Co.
Code Review Board
Code Review Board consists of five member companies participating in the Ethical Kampo Products Commission and the Crude Drugs Commission, in order to implement the Promotion Code for ethical Kampo formulation and crude drug.

Representative Member
Hiroyuki Matsuzuka, Kracie Pharmaceutical, Ltd.

 

Subcommittee for Product Information Summary
Head
Toshihiro Yamamura, Tsumura & Co.

NHI Pricing committee
The purpose of the NHI Pricing Committee is to contribute to the improvement of national medical care by ensuring the sustainable growth of ethical kampo formulations and crude drugs within systems such as medical insurance and the NHI drug price standard. The NHI Pricing Committee consists of 15 member companies.

Chairman
Nozomu Maruki, Tsumura & Co.